Angiotech Pharmaceuticals, Inc. (ANPI,ANP.TO) reported third quarter net loss of US$7.8 million or US$0.09 per share, compared to net loss of US$622.38 million or US$7.31 per share last year. The company noted that the prior year results were restated.
Adjusted net income was US$0.1 million or breakeven per share for the quarter.
Revenue declined to US$63.24 million from US$68.36 million in the same quarter last year.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.